Categories
News

Global Neurological Biomarkers Market Research 2020 Report | Growth Forecast 2026|Athena Diagnostics, Inc.;Quanterix;Immunarray Pvt. Ltd.;QIAGEN;Bio-Rad Laboratories, Inc.;BANYAN BIOMARKERS

GLOBAL NEUROLOGICAL BIOMARKERS MARKET is set to witness a healthy CAGR of 10.02% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Rising cases of neurological disorders and increasing technological advancement are the factor for the market growth.

Get Exclusive Sample Copy Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-neurological-biomarkers-market

Few of the major competitors currently working in the global neurological biomarkers market are Myriad RBM; Abbott; Thermo Fisher Scientific Inc;Athena Diagnostics, Inc.;Quanterix;Immunarray Pvt. Ltd.;QIAGEN;Bio-Rad Laboratories, Inc.;BANYAN BIOMARKERS, INC;Merck KGaA,;F. Hoffmann-La Roche Ltd;Janssen Global Services, LLC,;Charles River;Advanced Brain Monitoring, Inc.;Neurosteer;Quanterix; among others.

List of Chapters: 

1 Neurological Biomarkers Market Overview
2 Global Neurological Biomarkers Market Competitions by Manufacturers
3 Global Neurological Biomarkers Capacity, Production, Revenue (Value) by Region (2019-2026)
4 Global Neurological Biomarkers Supply (Production), Consumption, Export, Import by Region (2019-2026)
5 Global Neurological Biomarkers Production, Revenue (Value), Price Trend by Type
6 Global Neurological Biomarkers Market Analysis by Application
7 Global Neurological Biomarkers Manufacturers Profiles/Analysis
8 Neurological Biomarkers Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Neurological Biomarkers Market Forecast (2019-2026)
13 Research Findings and Conclusion
14 Appendix

Key Developments in the Market:

  • In June 2019, Quanterix Corporation announced the acquisition of UmanDiagnostics AB which will help the company to strengthen their assay development and supply abilities. The antibody and Elisa kits supplied by UmanDiagnostics can help the company to detect Nf-L which can be used to treat, predict and track a variety of conditions, including ALS, multiple sclerosis and other. This acquisition will help the company to develop new digital biomarkers to improve the field of neurological condition diagnostics science
  • In November 2017, Quanterix Corporation announced the launch of their new SR-X Ultra-Sensitive Biomarker Detection System. SR-X platform has the ability to detect neurological biomarkers that were historically observable only in cerebrospinal fluid. The SR-X has the ability to improve treatment of brain injuries and diseases by identifying neurological biomarkers much sooner and allowing us to consider the long-term effects and pathology of diseases

Market Drivers

    • Increasing demand for non-invasive diagnostic techniques for Alzheimer’s and Parkinson’s will drive the market growth
    • Growing demand for personalized medicine for neurological disorders also accelerates the market growth
  • Rising focus to create cost- effective biomarker testing will also propel the growth
  • Growing demand for genomics biomarker will also propel the market growth

Market Restraints

  • Strict government regulation will hamper the market growth
  • Emerging legal issues with early diagnosis of Alzheimer’s and Parkinson’s diseases also acts as a restricting factor for the growth of this market
  • The absence of pre-analytical tests will also hinder the market growth

To know more about the study @ https://www.databridgemarketresearch.com/reports/global-neurological-biomarkers-market

Segmentation: Global Neurological Biomarkers Market

By Product Type

  • Genomics Biomarker
  • Proteomics Biomarker
  • Imaging Biomarker
  • Metabolomics Biomarker
  • Others

By End-User

  • Clinical Diagnostics
  • Pharmaceutical And Biotechnology Companies
  • Research Organizations

By Indication

  • Spinal Muscular Atrophy
  • Parkinson’s Disease, Schizophrenia
  • Huntington’s Disease
  • Alzheimer’s Disease
  • Depression
  • Multiple Sclerosis

By Imaging Techniques

  • Transcranial Magnetic Stimulation
  • Diffusion Tensor Imaging, Conventional Structural MRI
  • Functional Magnetic Resonance Imaging
  • Positron Emission Tomography

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Inquire More or Share Questions if any before the Purchase on this Report    https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-neurological-biomarkers-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]